INS and Insulin resistance: Importantly, disruption of MAM integrity by genetic or pharmacological inhibition of CypD induced insulin resistance in mice and disrupted insulin signalling in human primary hepatocytes15, confirming that MAM disruption is sufficient to induce hepatic insulin resistance and altered glucose homeostasis in vivo.